The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them
The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them Moneycontrol Latest News Read More
हिन्दी 
English